Drug Newly Approved Ulcerative Colitis

Velsipity to treat active ulcerative colitis in adults

Drug Name: Velsipity

Active Ingredient: etrasimod

Indication: To treat moderately to severely active ulcerative colitis in adults

Approval Date: 10/12/2023

Company: Pfizer Inc

More: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-fda-and-ema-acceptance-etrasimod

Related

Drug Practice Process Research

Elevating Healthcare Conversations through AI-Enabled CI: KAI Conversations

Drug Practice Process Research

Revolutionizing Pharmacovigilance with AI: DrugCard

Drug Practice Procedure Process Research

Solving for Precision Medicine with AI-Enabled Solutions: Tempus